Israel vs Mexico: Cause of death, by non-communicable diseases, ages 5-14, female
Israel
58.8%
in 2021
Mexico
57.6%
in 2021
Israel rank
40th
Mexico rank
42nd
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Israel
- Mexico
How they compare
Israel currently reports 58.8% against 57.6% in Mexico, a difference of 1.2%.
Across all 6 years both countries report, Israel has been ahead every year.
Israel ranks 40th and Mexico ranks 42nd of 184 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.8% | 53.6% | 3.3% | Israel |
| 2010s | 67.3% | 59.6% | 7.7% | Israel |
| 2020s | 68.9% | 58.0% | 10.8% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Israel or Mexico?
- Israel, at 58.8% against 57.6% in Mexico as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Israel and Mexico?
- 1.2%, with Israel ahead.
- How many years of comparable data are there for Israel and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do Israel and Mexico rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Israel ranks 40th and Mexico ranks 42nd of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.